Evaluation of cerebral metabolism after CPAP treatment in OSAS patients Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in patients with OSAS with emphasis on gender differences Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Effects of CPAP treatment in UARS patients comparing to OSAS patients Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Cardiovascular risk markers in patients with OSA. Effects of CPAP treatment Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Effects of CPAP treatment on muscle strength in OSAS and OS patients Source: Eur Respir J 2002; 20: Suppl. 38, 499s Year: 2002
Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment Source: Eur Respir J 2007; 30: Suppl. 51, 335s Year: 2007
CPAP vs APAP effects on metabolic and cardiac function in patients with OSAS Source: Eur Respir J 2005; 26: Suppl. 49, 722s Year: 2005
Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Weight and metabolic effects of CPAP in OSA patients with obesity Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise Year: 2010
Predictors of compliance with CPAP in patients with OSA and metabolic syndrome Source: Annual Congress 2009 - Continuous positive airway pressure therapy in obstructive sleep apnoea Year: 2009
Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Long-term continuous positive airway pressure (nCPAP) treatment maintains the improvement of insulin sensitivity in patients with OSAS after 2.8 years Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Effect of continuous positive airway pressure on lipid profile in patients with severe OSAS Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018
Effects of CPAP treatment on exercise performance and gas exchange in OSAS and OS patients Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002
Effect of CPAP treatment on endothelial function, inflammatory markers, blood pressure and glucose control in male and female patients with OSAS Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Energy expenditure in obese OSAS patients before and after CPAP therapy Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
Risk of obstructive sleep apnea and impaired glucose metabolism in non-diabetic subjects Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019
Physiological and anthropometric differences among OSA patients requiring CPAP or autoBiPAP Mseries® treatment Source: Annual Congress 2010 - Complex sleep apnoea, opioids, adaptive servoventilation, bilateral positive airway pressure and continuous positive airway pressure Year: 2010
Effect of CPAP adherence on depression in OSA patient Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects Year: 2020
Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004